XML 32 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Goodwill and Other Intangible Assets
9 Months Ended
Sep. 30, 2013
Goodwill and Other Intangible Assets  
Goodwill and Other Intangible Assets

 

 

6.              Goodwill and Other Intangible Assets

 

The following table sets forth the changes in the carrying amount of goodwill for the nine months ended September 30, 2013 (in millions):

 

Balance at December 31, 2012

 

$

115.9

 

Current period additions

 

9.6

 

Current period adjustments

 

0.3

 

Foreign currency effect

 

0.8

 

Balance at September 30, 2013

 

$

126.6

 

 

Goodwill is not amortized, instead, goodwill is tested for impairment on a reporting unit basis annually, or on an interim basis when events or changes in circumstances warrant. As of December 31, 2012, the Company performed its annual impairment evaluation and recorded an impairment charge of $1.4 million in the fourth quarter of 2012 related to the Bruker Chemical and Applied Markets (“CAM”) division, which is part of the BSI segment, as a result of experiencing increased deterioration in its financial performance. This amount represented all the goodwill allocated to the CAM division.  The Company did not identify any indicators of impairment during the three and nine month periods ended September 30, 2013 that would warrant an interim test.  The current period additions relate to acquisitions that are not considered significant to the condensed consolidated financial statements.

 

The following is a summary of intangible assets (in millions):

 

 

 

September 30, 2013

 

December 31, 2012

 

 

 

Gross
Carrying
Amount

 

Accumulated
Amortization

 

Net Carrying
Amount

 

Gross
Carrying
Amount

 

Accumulated
Amortization

 

Net Carrying
Amount

 

Existing technology and related patents

 

$

152.0

 

$

(58.2

)

$

93.8

 

$

151.5

 

$

(47.6

)

$

103.9

 

Customer relationships

 

17.9

 

(9.0

)

8.9

 

15.3

 

(7.9

)

7.4

 

Trade names

 

0.2

 

(0.2

)

 

0.2

 

(0.2

)

 

Intangible assets subject to amortization

 

170.1

 

(67.4

)

102.7

 

167.0

 

(55.7

)

111.3

 

In-process research and development

 

5.7

 

 

5.7

 

5.7

 

 

5.7

 

Intangible assets

 

$

175.8

 

$

(67.4

)

$

108.4

 

$

172.7

 

$

(55.7

)

$

117.0

 

 

As of December 31, 2012, the Company determined the increased deterioration in financial performance of the CAM division was an indicator requiring the evaluation of the definite-lived intangible assets within that reporting unit for recoverability. The Company performed a valuation and determined that the definite-lived intangible assets within the CAM division were impaired. The Company recorded an impairment charge in the amount of $16.4 million in the fourth quarter of 2012 to reduce the carrying value of those assets to their estimated fair values. The Company did not identify any indicators of impairment during the three and nine month periods ended September 30, 2013 that would warrant an impairment test.

 

For the three months ended September 30, 2013 and 2012, the Company recorded amortization expense of $5.1 million and $5.5 million, respectively, related to intangible assets subject to amortization. For the nine months ended September 30, 2013 and 2012, the Company recorded amortization expense of $15.3 million and $16.2 million, respectively, related to intangible assets subject to amortization.